152 related articles for article (PubMed ID: 28676451)
21. [What signs should you look for ultrasound (2D/3D) to affirm the good location of tubal implants? About a retrospective study of 92 cases].
Simorre M; Lopes P; Le Vaillant C
Gynecol Obstet Fertil; 2016 Oct; 44(10):572-577. PubMed ID: 27318772
[TBL] [Abstract][Full Text] [Related]
22. Algorithm of Transvaginal Ultrasound and/or Hysterosalpingogram for Confirmation Testing at 3 Months after Essure Placement.
Vleugels M; Cheng RF; Goldstein J; Bangerter K; Connor V
J Minim Invasive Gynecol; 2017; 24(7):1128-1135. PubMed ID: 28669895
[TBL] [Abstract][Full Text] [Related]
23. Hysteroscopic tubal sterilization (essure) in women with an intrauterine device.
Agostini A; Crochet P; Petrakian M; Estrade JP; Cravello L; Gamerre M
J Minim Invasive Gynecol; 2008; 15(3):277-9. PubMed ID: 18439497
[TBL] [Abstract][Full Text] [Related]
24. Essure Permanent Birth Control, Effectiveness and Safety: An Italian 11-Year Survey.
Franchini M; Zizolfi B; Coppola C; Bergamini V; Bonin C; Borsellino G; Busato E; Calabrese S; Calzolari S; Fantin GP; Giarrè G; Litta P; Luerti M; Mangino FP; Marchino GL; Molinari MA; Scatena E; Scrimin F; Telloli P; Di Spiezio Sardo A
J Minim Invasive Gynecol; 2017; 24(4):640-645. PubMed ID: 28232037
[TBL] [Abstract][Full Text] [Related]
25. Tubal perforation by Essure: three different clinical presentations.
Langenveld J; Veersema S; Bongers MY; Koks CA
Fertil Steril; 2008 Nov; 90(5):2011.e5-10. PubMed ID: 18692813
[TBL] [Abstract][Full Text] [Related]
26. Sonography, CT, and MRI appearance of the Essure microinsert permanent birth control device.
Wittmer MH; Brown DL; Hartman RP; Famuyide AO; Kawashima A; King BF
AJR Am J Roentgenol; 2006 Oct; 187(4):959-64. PubMed ID: 16985143
[TBL] [Abstract][Full Text] [Related]
27. [Ultrasonography as a method to determine the correct implantation of intratubaric devices].
García-Lavandeira S; Vázquez-Rodríguez M; Blanco-Pérez S; Pato-Mosquera M; Janeiro-Freire MJ; Araújo-Fernández JE
Ginecol Obstet Mex; 2014 Aug; 82(8):523-9. PubMed ID: 25282944
[TBL] [Abstract][Full Text] [Related]
28. Clinical experience with contrast infusion sonography as an Essure confirmation test.
Connor VF
J Ultrasound Med; 2011 Jun; 30(6):803-8. PubMed ID: 21632995
[TBL] [Abstract][Full Text] [Related]
29. Confirmation Testing of Essure Microinserts in Unintended Pregnancies Using a 10-Year Retrospective Database.
Rattray D; Thiel P; Suchet I; Thiel J
J Minim Invasive Gynecol; 2016; 23(6):944-8. PubMed ID: 27257083
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of Essure placement in intrauterine device users.
Mascaro M; Mariño M; Vicens-Vidal M
J Minim Invasive Gynecol; 2008; 15(4):485-90. PubMed ID: 18602048
[TBL] [Abstract][Full Text] [Related]
31. Radiological assessment of placement of the hysteroscopically inserted Essure permanent birth control device.
Lorente Ramos RM; Azpeitia Armán J; Aparicio Rodríguez-Miñón P; Salazar Arquero FJ; Albillos Merino JC
Radiologia; 2015; 57(3):193-200. PubMed ID: 25656567
[TBL] [Abstract][Full Text] [Related]
32. Essure microinsert hysteroscopic tubal sterilization: eight-years follow-up results.
Sakinci M; Aksu T; Kuru O; Ozekinci M; Sanhal C
Clin Exp Obstet Gynecol; 2015; 42(1):72-8. PubMed ID: 25864287
[TBL] [Abstract][Full Text] [Related]
33. Can hysterosalpingo-contrast sonography replace hysterosalpingography in confirming tubal blockage after hysteroscopic sterilization and in the evaluation of the uterus and tubes in infertile patients?
Luciano DE; Exacoustos C; Johns DA; Luciano AA
Am J Obstet Gynecol; 2011 Jan; 204(1):79.e1-5. PubMed ID: 21187197
[TBL] [Abstract][Full Text] [Related]
34. Dislodged Essure microinsert.
Booker CJ; Yarwood RL; Dodson WC
Fertil Steril; 2008 Apr; 89(4):964-5. PubMed ID: 18054922
[TBL] [Abstract][Full Text] [Related]
35. The safety and effectiveness of a new hysteroscopic method for permanent birth control: results of the first Essure pbc clinical study.
Kerin JF; Carignan CS; Cher D
Aust N Z J Obstet Gynaecol; 2001 Nov; 41(4):364-70. PubMed ID: 11787907
[TBL] [Abstract][Full Text] [Related]
36. Learning curve of hysteroscopic placement of tubal sterilization microinserts in 15 gynecologists in the Netherlands.
Janse JA; Pattij TO; Eijkemans MJ; Broekmans FJ; Veersema S; Schreuder HW
Fertil Steril; 2013 Sep; 100(3):755-60. PubMed ID: 23768989
[TBL] [Abstract][Full Text] [Related]
37. Automated three-dimensional coded contrast imaging hysterosalpingo-contrast sonography: feasibility in office tubal patency testing.
Exacoustos C; Di Giovanni A; Szabolcs B; Romeo V; Romanini ME; Luciano D; Zupi E; Arduini D
Ultrasound Obstet Gynecol; 2013 Mar; 41(3):328-35. PubMed ID: 22648792
[TBL] [Abstract][Full Text] [Related]
38. Contrast infusion sonography in the post-Essure setting.
Connor V
J Minim Invasive Gynecol; 2008; 15(1):56-61. PubMed ID: 18262145
[TBL] [Abstract][Full Text] [Related]
39. Ultrasound: an effective method for localization of the echogenic Essure sterilization micro-insert: correlation with radiologic evaluations.
Kerin JF; Levy BS
J Minim Invasive Gynecol; 2005; 12(1):50-4. PubMed ID: 15904599
[TBL] [Abstract][Full Text] [Related]
40. Office ultrasound should be the first-line investigation for confirmation of correct ESSURE placement.
Weston G; Bowditch J
Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):312-5. PubMed ID: 16029299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
